Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Sunshine Biopharma (SBFM) over the last 14 years, with Dec 2024 value amounting to $4.0 million.

  • Sunshine Biopharma's Change in Accured Expenses rose 316.50% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 46.59%. This contributed to the annual value of $4.0 million for FY2024, which is 392.04% up from last year.
  • As of FY2024, Sunshine Biopharma's Change in Accured Expenses stood at $4.0 million, which was up 392.04% from -$1.4 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Change in Accured Expenses ranged from a high of $4.0 million in FY2024 and a low of -$1.4 million during FY2023.
  • In the last 3 years, Sunshine Biopharma's Change in Accured Expenses had a median value of $3.4 million in 2022 and averaged $2.0 million.
  • In the last 5 years, Sunshine Biopharma's Change in Accured Expenses tumbled by 397.06% in 2020 and then surged by 13,915.69% in 2022.
  • Sunshine Biopharma's Change in Accured Expenses (Yearly) stood at -$35,012 in 2020, then spiked by 168.45% to $23,967 in 2021, then soared by 13,915.69% to $3.4 million in 2022, then tumbled by 140.61% to -$1.4 million in 2023, then skyrocketed by 392.04% to $4.0 million in 2024.